News for Reading International, Inc. (RDI)

Andrzej Matyczynski: This is the Earnings Call script for the Fourth Quarter 2024. Thank you for joining Reading International's Earnings Call to discuss our 2024 Fourth Quarter and Full Year Results.

Reading International Inc (RDI) released its 8-K filing on April 3, 2025, reporting a robust fourth quarter for 2024. The company, known for its diversified ope

Reading International, Inc. (NASDAQ:RDI) Q4 2024 Results Conference Call April 2, 2025 4:30 PM ETCompany ParticipantsAndrzej Matyczynski - Executive Vice...

Liberty Media Corporation - Series C Liberty Formula One (FWONK) experienced a significant stock movement with a 5.05% increase in its share price. The stock is

AMC Networks (AMCX) experienced a notable stock movement with a 5.04% increase in its share price, reaching $9.92. The trading volume was 122,531 shares, with a

Reading International reports strong 2024 Holiday Box Office Results

**media[521680]**

NEW YORK, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Reading International, Inc. ( RDI) (”œReading” or our ”œCompany”), an internationally diversified cinema and

Reading International sells Wellington properties in New Zealand for NZ$38 million to Prime Property Group.

Reading International (B) stock hits 52-week low at $5.96

Release Date: November 18, 2024For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Reading Inte

Reading International, Inc. (NASDAQ:RDI) Q3 2024 Earnings Conference Call November 18, 2024 9:00 AM ETCompany ParticipantsAndrzej Matyczynski - Executive...

Disney's (DIS) stock experienced a significant 5% increase, trading at $114.58 per share with a trading volume of 19.11 million shares and a turnover rate of 1.

**media[436129]**

U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Friday. Here are some big stocks recording gains in today’s session.

Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.

Read Analysts’ New Coverage for May 29th (AACG, AAME, ABEO, ACOR, ACRX, ACU, AEMD, AEY, AEZS, AGFS) at ETF Daily News

Read Investment Analysts’ New Coverage for May 21st (AACG, AAME, ABEO, ACOR, ACRX, ACU, AEMD, AEY, AEZS, AGFS) at ETF Daily News

GuruFocus Article or News written by insider and the topic is about: